TRV130 + Morphine + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Pain
Conditions
Acute Pain
Trial Timeline
Apr 1, 2014 → Oct 1, 2014
NCT ID
NCT02100748About TRV130 + Morphine + Placebo
TRV130 + Morphine + Placebo is a phase 2 stage product being developed by Trevena for Acute Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02100748. Target conditions include Acute Pain.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02335294 | Phase 2 | Completed |
| NCT02100748 | Phase 2 | Completed |
Competing Products
20 competing products in Acute Pain